With a proven track record in healthcare innovation and commercialization, Salgado will drive health plan, health system and employer growth to improve access to Welldoc’s chronic care platform

Welldoc®, a digital health leader revolutionizing chronic care, today announced the appointment of Simon Salgado as Chief Revenue Officer. In this role, Salgado will lead commercial growth across health plans, health systems and employers, empowering more people living with chronic conditions to access Welldoc’s digital health platform which enables improved health and outcomes.

“We are delighted to welcome Simon to Welldoc. His extensive expertise in leading the development, deployment and commercialization of healthcare services will be a key asset as we partner with health plans, health systems and employers to extend care beyond traditional models. I look forward to Welldoc’s next stage of growth with Simon on our team,” said Keith Reynolds, Chief Operating Officer of Welldoc.”

Prior to joining Welldoc, Salgado spent more than 15 years leading teams that developed and commercialized innovative and mission-based healthcare offerings that improve patient health and deliver strong business results. Most recently as Vice President of Enterprise Health Services at Podimetrics, Salgado successfully led the go-to-market expansion into the payor market, expanding access to diabetic amputation prevention via SmartMat technology. In addition, Salgado has deep product innovation, development and payor sales experience from leadership roles over his more than 10 years with CVS Health and prior, as a Strategy and Operations Consultant with Deloitte.

“Welldoc is a proven trailblazer and leader in the ever-evolving, diverse digital health space,” said Salgado. “The mission-driven company is powering a shift in the healthcare landscape with an evidence-based AI-driven platform, and I’m humbled to be a part of a team so dedicated to transforming chronic care and improving health outcomes.”

Salgado succeeds Dave Driscoll, who served as Chief Revenue Officer since August of 2020. During his tenure, Driscoll was instrumental in enhancing Welldoc’s commercial approach and building significant market momentum. Driscoll will continue supporting Welldoc’s commercialization efforts as Senior Vice President of Provider Sales. “We are grateful for Dave’s contributions and look forward to his continued impacts as he moves into a new role helping the company expand our market presence in the health system and provider space,” said Reynolds.

About Welldoc

Welldoc^®, a digital health leader revolutionizing chronic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with chronic conditions, enabling improved health and outcomes. Welldoc’s comprehensive chronic care platform provides multi-condition support across diabetes, hypertension, heart failure and behavioral health. Welldoc’s flagship product, BlueStar^®, an FDA-cleared digital health solution, guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. Welldoc partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs. For more information, visit www.welldoc.com. Follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220913005907/en/